Economic evaluation of lifestyle interventions for preventing diabetes and cardiovascular diseases.
about
Lifestyle Interventions to Prevent Type 2 Diabetes: A Systematic Review of Economic Evaluation StudiesRationale and design of the PREDICE project: cost-effectiveness of type 2 diabetes prevention among high-risk Spanish individuals following lifestyle intervention in real-life primary care settingLifestyle interventions to reduce diabetes and cardiovascular disease risk among children.Cost-effectiveness of cardiovascular risk management by practice nurses in primary careJoint Association of Dietary Pattern and Physical Activity Level with Cardiovascular Disease Risk Factors among Chinese Men: A Cross-Sectional Study.Impact of hemoglobin A1c-based criterion on diagnosis of prediabetes: The Korea National Health and Nutrition Examination Survey 2011.Insights offered by economic analyses.Estimating the cost-effectiveness of lifestyle intervention programmes to prevent diabetes based on an example from Germany: Markov modelling.An economic evaluation alongside a randomized controlled trial evaluating an individually tailored lifestyle intervention compared with usual care in people with familial hypercholesterolemiaImpact of HbA1c Criterion on the Detection of Subjects with Increased Risk for Diabetes among Health Check-Up Recipients in KoreaTesting the Short-Term Efficacy of a Lipid-Lowering Nutraceutical in the Setting of Clinical Practice: A Multicenter StudyAssociation of physical activity on body composition, cardiometabolic risk factors, and prevalence of cardiovascular disease in the Korean population (from the fifth Korea national health and nutrition examination survey, 2008-2011).The economic costs of diabetes: is it time for a new treatment paradigm?Obesity and Insulin Resistance Are the Central Issues in Prevention of and Care for Comorbidities.Heterogeneity in cost-effectiveness of lifestyle counseling for metabolic syndrome risk groups -primary care patients in Sweden.Are lifestyle interventions in primary care cost-effective?--An analysis based on a Markov model, differences-in-differences approach and the Swedish Björknäs study.Therapeutic interventions to reduce the risk of progression from prediabetes to type 2 diabetes mellitusThe impact of diabetes mellitus on healthcare costs in Italy.The long-term cost-effectiveness of obesity prevention interventions: systematic literature review.Tolerability and safety of commonly used dietary supplements and nutraceuticals with lipid-lowering effects.Rational use of electronic health records for diabetes population management.Systematic review and overview of health economic evaluation models in obesity prevention and therapy.Berberine and Its Role in Chronic Disease.Effects of a Combined Nutraceutical on Lipid Pattern, Glucose Metabolism and Inflammatory Parameters in Moderately Hypercholesterolemic Subjects: A Double-blind, Cross-over, Randomized Clinical Trial.The cost-effectiveness of interventions targeting lifestyle change for the prevention of diabetes in a Swedish primary care and community based prevention program.Computer simulation models of pre-diabetes populations: a systematic review protocol.Cost effectiveness and return on investment of a scalable community weight loss intervention.Preventing type 2 diabetes: systematic review of studies of cost-effectiveness of lifestyle programmes and metformin, with and without screening, for pre-diabetes.A Systematic Review of Behavioural Interventions Promoting Healthy Eating among Older People.Economic evaluation of type 2 diabetes prevention programmes: Markov model of low- and high-intensity lifestyle programmes and metformin in participants with different categories of intermediate hyperglycaemia.Valuing a Lifestyle Intervention for Middle Eastern Immigrants at Risk of Diabetes.Klinische Ergebnisse, gesundheitsbezogene Lebensqualität und Kosten-Effektivität eines 6-monatigen Programms zur Lebensstilmodifikation bei Personen mit erhöhtem kardioväskularen Risiko in Niederösterreich
P2860
Q26765194-B2BB394C-91BA-4B60-8487-7F2183F66CC4Q33989592-4A58DD8A-D301-43AC-975F-68751AE7A018Q34403413-DB09AE79-E5AD-4E40-97A9-DA81A8DDE7ECQ34590592-75FD3390-57D3-4957-982A-701998828853Q34805185-23925CA5-3D15-481E-8F8C-B74AB78D44B3Q34976683-4D956359-F77D-44F8-BC90-4E707E049427Q35360916-D9DFC69B-703C-4FB8-B963-4B8FAEB483C0Q35666642-16661EBB-A582-43D7-9F1C-F886FB75732DQ35720690-90D3CEF7-65B6-4133-BEDE-EEA704DA1F54Q35911085-8F1BB5AB-606D-4F71-957F-16B65AE3A542Q36263531-778B116F-6C46-4C5B-BD83-ED1CF625DA4BQ36317403-7CF247F6-34E1-4CBD-A68C-6206246D71B3Q36720338-BAA3FD91-F482-4255-850D-58AC2CFFCC92Q37081549-00515E15-655D-4364-B6D7-FC68AB556343Q37153047-364E69E0-EDFC-4260-B6EF-4EA748A459C3Q37309025-2120DDF7-4D95-42E3-9442-6CFF67F000E0Q37660219-1C505D78-F0F3-4200-913E-97CB92D2B0DAQ37958055-0FF4881B-57D3-49F6-870F-66B87F1BF9FDQ37976483-F9B8D65C-BF68-469D-AAE2-56356AC05050Q38025713-2D9A5E04-83FE-47D4-AC82-EA4C685E84F1Q38194938-BFC88F34-9AD6-4F89-9AAD-566788AEA97DQ38826997-555B1F6E-4C10-4369-BD5A-16B618BAE578Q38965186-57BD0A81-900C-4D1E-9DE9-E278C1F6C2EBQ39658352-EB05C6BD-62C3-4FC2-98AB-B599E7D7F2C2Q40443814-ACD5B8F7-0BD4-44DA-91E9-12AE278AFE59Q42376789-34C9A715-A266-4043-8674-FC2492B83910Q45069487-B38AEFC7-617D-4896-9635-0B5B19E6CC37Q47160040-1DE48FA8-53A0-4B50-AF9D-608089580EF5Q48159426-E257356C-BEAD-4C10-8A22-9919FB7226D1Q49193888-198BDC56-DF5B-4561-925B-8FCB77F92F79Q55262056-FBA3151E-F55F-4D3D-B936-30208B671266Q57338281-A8741650-94D2-42F1-9E0F-BBCD35DC2757
P2860
Economic evaluation of lifestyle interventions for preventing diabetes and cardiovascular diseases.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Economic evaluation of lifesty ...... s and cardiovascular diseases.
@ast
Economic evaluation of lifesty ...... s and cardiovascular diseases.
@en
Economic evaluation of lifesty ...... s and cardiovascular diseases.
@nl
type
label
Economic evaluation of lifesty ...... s and cardiovascular diseases.
@ast
Economic evaluation of lifesty ...... s and cardiovascular diseases.
@en
Economic evaluation of lifesty ...... s and cardiovascular diseases.
@nl
prefLabel
Economic evaluation of lifesty ...... s and cardiovascular diseases.
@ast
Economic evaluation of lifesty ...... s and cardiovascular diseases.
@en
Economic evaluation of lifesty ...... s and cardiovascular diseases.
@nl
P2860
P356
P1476
Economic evaluation of lifesty ...... es and cardiovascular diseases
@en
P2093
Pia Johansson
P2860
P304
P356
10.3390/IJERPH7083150
P5008
P577
2010-08-09T00:00:00Z